Impact of Allergen Immunotherapy Labeling and Dosing Diversity at the “Big 10” Universities' Health Services
Results At the time of data collection, 17 individuals treating an estimated 1200 AIT patients at 9 out of the 15 "Big 10" universities responded to the questionnaire. 75% of patients received AIT prescribed by allergists not affiliated with the UHS. 70% of the time, AIT extract vial label...
Gespeichert in:
| Veröffentlicht in: | Journal of allergy and clinical immunology 2015-02, Vol.135 (2), p.AB235-AB235 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | AB235 |
|---|---|
| container_issue | 2 |
| container_start_page | AB235 |
| container_title | Journal of allergy and clinical immunology |
| container_volume | 135 |
| creator | Holland, Christine L., MD Samuels, Kiela, PharmD Sanders, Georgiana M., MD, MS, FAAAAI Karam, Marilyn R., MD |
| description | Results At the time of data collection, 17 individuals treating an estimated 1200 AIT patients at 9 out of the 15 "Big 10" universities responded to the questionnaire. 75% of patients received AIT prescribed by allergists not affiliated with the UHS. 70% of the time, AIT extract vial labels were missing one or more of the following recommended components: 2 patient identifiers, dilution of extract in volume/volume (v/v) format with its corresponding color coding, allergen content and expiration date. 16 out of 17 (94%) respondents felt that labels containing all these components would decrease error when administering AIT. |
| doi_str_mv | 10.1016/j.jaci.2014.12.1703 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1660395915</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0091674914034848</els_id><sourcerecordid>3585111581</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1605-9bab7ccdd161c79153ab8e4e7f9a8a619d7f1bdfec9bb122b2286a46ef9428043</originalsourceid><addsrcrecordid>eNpdkc1q3DAQgEVpodttn6AXQQ_txY5GsiXrUkiTJllYyCHJWcjyeCPXf5W8C3vLg7QvlyepzQYCPWmEvvnRfIR8BpYCA3nWpI11PuUMshR4CoqJN2QFTKtEFjx_S1aMaUikyvR78iHGhs13UegVGTfdaN1Eh5qety2GHfZ003X7fpgeMdjxSLe2xNb3O2r7il4OcQkv_QFD9NOR2onOIH1--vPD7yiw56e_9KF_efYYv9IbtO30SO8wHLzD-JG8q20b8dPLuSYPVz_vL26S7e315uJ8mziQLE90aUvlXFWBBKc05MKWBWaoam0LK0FXqoayqtHpsgTOS84LaTOJtc54wTKxJt9Odccw_N5jnEzno8O2tT0O-2hASiZ0vlReky__oc2wD_083UzlXCkuhJ4pcaJcGGIMWJsx-M6GowFmFgumMYsFs1gwwM1iYc76fsrC-a8Hj8G4eZne2fYXHjG-NjKRG2buFk-LJsiYyIqsEP8AnYOSlQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1652772339</pqid></control><display><type>article</type><title>Impact of Allergen Immunotherapy Labeling and Dosing Diversity at the “Big 10” Universities' Health Services</title><source>Elsevier ScienceDirect Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Holland, Christine L., MD ; Samuels, Kiela, PharmD ; Sanders, Georgiana M., MD, MS, FAAAAI ; Karam, Marilyn R., MD</creator><creatorcontrib>Holland, Christine L., MD ; Samuels, Kiela, PharmD ; Sanders, Georgiana M., MD, MS, FAAAAI ; Karam, Marilyn R., MD</creatorcontrib><description>Results At the time of data collection, 17 individuals treating an estimated 1200 AIT patients at 9 out of the 15 "Big 10" universities responded to the questionnaire. 75% of patients received AIT prescribed by allergists not affiliated with the UHS. 70% of the time, AIT extract vial labels were missing one or more of the following recommended components: 2 patient identifiers, dilution of extract in volume/volume (v/v) format with its corresponding color coding, allergen content and expiration date. 16 out of 17 (94%) respondents felt that labels containing all these components would decrease error when administering AIT.</description><identifier>ISSN: 0091-6749</identifier><identifier>EISSN: 1097-6825</identifier><identifier>DOI: 10.1016/j.jaci.2014.12.1703</identifier><language>eng</language><publisher>St. Louis: Elsevier Limited</publisher><subject>Allergy and Immunology ; Efficiency ; Health care industry ; Hospitals ; Immunotherapy ; Patient safety</subject><ispartof>Journal of allergy and clinical immunology, 2015-02, Vol.135 (2), p.AB235-AB235</ispartof><rights>Copyright Elsevier Limited Feb 2015</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids></links><search><creatorcontrib>Holland, Christine L., MD</creatorcontrib><creatorcontrib>Samuels, Kiela, PharmD</creatorcontrib><creatorcontrib>Sanders, Georgiana M., MD, MS, FAAAAI</creatorcontrib><creatorcontrib>Karam, Marilyn R., MD</creatorcontrib><title>Impact of Allergen Immunotherapy Labeling and Dosing Diversity at the “Big 10” Universities' Health Services</title><title>Journal of allergy and clinical immunology</title><description>Results At the time of data collection, 17 individuals treating an estimated 1200 AIT patients at 9 out of the 15 "Big 10" universities responded to the questionnaire. 75% of patients received AIT prescribed by allergists not affiliated with the UHS. 70% of the time, AIT extract vial labels were missing one or more of the following recommended components: 2 patient identifiers, dilution of extract in volume/volume (v/v) format with its corresponding color coding, allergen content and expiration date. 16 out of 17 (94%) respondents felt that labels containing all these components would decrease error when administering AIT.</description><subject>Allergy and Immunology</subject><subject>Efficiency</subject><subject>Health care industry</subject><subject>Hospitals</subject><subject>Immunotherapy</subject><subject>Patient safety</subject><issn>0091-6749</issn><issn>1097-6825</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><recordid>eNpdkc1q3DAQgEVpodttn6AXQQ_txY5GsiXrUkiTJllYyCHJWcjyeCPXf5W8C3vLg7QvlyepzQYCPWmEvvnRfIR8BpYCA3nWpI11PuUMshR4CoqJN2QFTKtEFjx_S1aMaUikyvR78iHGhs13UegVGTfdaN1Eh5qety2GHfZ003X7fpgeMdjxSLe2xNb3O2r7il4OcQkv_QFD9NOR2onOIH1--vPD7yiw56e_9KF_efYYv9IbtO30SO8wHLzD-JG8q20b8dPLuSYPVz_vL26S7e315uJ8mziQLE90aUvlXFWBBKc05MKWBWaoam0LK0FXqoayqtHpsgTOS84LaTOJtc54wTKxJt9Odccw_N5jnEzno8O2tT0O-2hASiZ0vlReky__oc2wD_083UzlXCkuhJ4pcaJcGGIMWJsx-M6GowFmFgumMYsFs1gwwM1iYc76fsrC-a8Hj8G4eZne2fYXHjG-NjKRG2buFk-LJsiYyIqsEP8AnYOSlQ</recordid><startdate>20150201</startdate><enddate>20150201</enddate><creator>Holland, Christine L., MD</creator><creator>Samuels, Kiela, PharmD</creator><creator>Sanders, Georgiana M., MD, MS, FAAAAI</creator><creator>Karam, Marilyn R., MD</creator><general>Elsevier Limited</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7SS</scope><scope>7T5</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope></search><sort><creationdate>20150201</creationdate><title>Impact of Allergen Immunotherapy Labeling and Dosing Diversity at the “Big 10” Universities' Health Services</title><author>Holland, Christine L., MD ; Samuels, Kiela, PharmD ; Sanders, Georgiana M., MD, MS, FAAAAI ; Karam, Marilyn R., MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1605-9bab7ccdd161c79153ab8e4e7f9a8a619d7f1bdfec9bb122b2286a46ef9428043</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Allergy and Immunology</topic><topic>Efficiency</topic><topic>Health care industry</topic><topic>Hospitals</topic><topic>Immunotherapy</topic><topic>Patient safety</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Holland, Christine L., MD</creatorcontrib><creatorcontrib>Samuels, Kiela, PharmD</creatorcontrib><creatorcontrib>Sanders, Georgiana M., MD, MS, FAAAAI</creatorcontrib><creatorcontrib>Karam, Marilyn R., MD</creatorcontrib><collection>CrossRef</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><jtitle>Journal of allergy and clinical immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Holland, Christine L., MD</au><au>Samuels, Kiela, PharmD</au><au>Sanders, Georgiana M., MD, MS, FAAAAI</au><au>Karam, Marilyn R., MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Impact of Allergen Immunotherapy Labeling and Dosing Diversity at the “Big 10” Universities' Health Services</atitle><jtitle>Journal of allergy and clinical immunology</jtitle><date>2015-02-01</date><risdate>2015</risdate><volume>135</volume><issue>2</issue><spage>AB235</spage><epage>AB235</epage><pages>AB235-AB235</pages><issn>0091-6749</issn><eissn>1097-6825</eissn><abstract>Results At the time of data collection, 17 individuals treating an estimated 1200 AIT patients at 9 out of the 15 "Big 10" universities responded to the questionnaire. 75% of patients received AIT prescribed by allergists not affiliated with the UHS. 70% of the time, AIT extract vial labels were missing one or more of the following recommended components: 2 patient identifiers, dilution of extract in volume/volume (v/v) format with its corresponding color coding, allergen content and expiration date. 16 out of 17 (94%) respondents felt that labels containing all these components would decrease error when administering AIT.</abstract><cop>St. Louis</cop><pub>Elsevier Limited</pub><doi>10.1016/j.jaci.2014.12.1703</doi></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0091-6749 |
| ispartof | Journal of allergy and clinical immunology, 2015-02, Vol.135 (2), p.AB235-AB235 |
| issn | 0091-6749 1097-6825 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1660395915 |
| source | Elsevier ScienceDirect Journals; EZB-FREE-00999 freely available EZB journals |
| subjects | Allergy and Immunology Efficiency Health care industry Hospitals Immunotherapy Patient safety |
| title | Impact of Allergen Immunotherapy Labeling and Dosing Diversity at the “Big 10” Universities' Health Services |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T14%3A11%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Impact%20of%20Allergen%20Immunotherapy%20Labeling%20and%20Dosing%20Diversity%20at%20the%20%E2%80%9CBig%2010%E2%80%9D%20Universities'%20Health%20Services&rft.jtitle=Journal%20of%20allergy%20and%20clinical%20immunology&rft.au=Holland,%20Christine%20L.,%20MD&rft.date=2015-02-01&rft.volume=135&rft.issue=2&rft.spage=AB235&rft.epage=AB235&rft.pages=AB235-AB235&rft.issn=0091-6749&rft.eissn=1097-6825&rft_id=info:doi/10.1016/j.jaci.2014.12.1703&rft_dat=%3Cproquest_cross%3E3585111581%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1652772339&rft_id=info:pmid/&rft_els_id=1_s2_0_S0091674914034848&rfr_iscdi=true |